Baird Medical Investment Holdings Limited
Price Action
Technical Summary
CONSOLIDATINGBaird Medical Investment Holdings Limited is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 33), showing significant lag compared to the market leaders. Investors should exercise caution due to high volatility (138% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.76 | +5.38% | ABOVE |
| 50 SMA | $2.09 | -10.85% | BELOW |
| 100 SMA | $1.67 | +11.38% | ABOVE |
| 150 SMA | $1.60 | +16.30% | ABOVE |
| 200 SMA | $1.78 | +4.72% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BDMD in an uptrend right now?
BDMD has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is BDMD overbought or oversold?
BDMD's RSI (14) is 48. The stock is in neutral territory, neither overbought nor oversold.
Is BDMD outperforming the market?
BDMD has a Relative Strength (RS) Rating of 33 out of 99. BDMD is currently lagging the broader market.
Where is BDMD in its 52-week range?
BDMD is trading at $1.86, which is 26% of its 52-week high ($7.26) and 17% above its 52-week low ($0.76).
How volatile is BDMD?
BDMD has a Beta of 1.15 and 52-week volatility of 138%. It's more volatile than the S&P 500 - expect bigger swings.